Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule

Proceedings of the National Academy of Sciences of the United States of America
Barbara J BlanchardVernon M Ingram

Abstract

The Abeta1-42 peptide that is overproduced in Alzheimer's disease (AD) from a large precursor protein has a normal amino acid sequence but, when liberated, misfolds at neutral pH to form "protofibrils" and fibrils that are rich in beta-sheets. We find that these protofibrils or fibrils are toxic to certain neuronal cells that carry Ca-permeant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Disrupting the structure of the Abeta1-42 fibrils and protofibrils might lead to the discovery of molecules that would be very useful in the treatment of AD. A high-throughput screen of a library of >3,000 small molecules with known "biological activity" was set up to find compounds that efficiently decrease the beta-sheet content of aggregating Abeta1-42. Lead compounds were characterized by using thioflavin T (ThT) as a beta-sheet assay. The most effective of six compounds found was 4,5-dianilinophthalimide (DAPH) under the following conditions: DAPH at low micromolar concentrations abolishes or greatly reduces previously existing fully formed Abeta1-42 fibrils, producing instead amorphous materials without fibrils but apparently containing some protofibrils and smaller forms. Coincubation of the Abeta1-42 peptid...Continue Reading

References

Aug 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
Jan 1, 1997·Molecular and Cellular Neurosciences·A FerreiraK S Kosik
Oct 6, 2000·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Y FezouiD B Teplow
Jun 11, 2002·Biochemical and Biophysical Research Communications·Barbara J BlanchardVernon M Ingram
Jun 11, 2002·Biochemical and Biophysical Research Communications·Barbara J BlanchardVernon M Ingram
Aug 28, 2002·Biochemical Society Transactions·D M WalshD J Selkoe
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Barbara J. BlanchardVernon M. Ingram
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Dennis J Selkoe, Dale Schenk
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gal BitanDavid B Teplow
Oct 1, 1953·Journal of Bacteriology·R C WILLIAMS, D FRASER

❮ Previous
Next ❯

Citations

Aug 6, 2013·Journal of Inorganic Biochemistry·Xuesong WangWeihong Du
Jun 29, 2007·Expert Reviews in Molecular Medicine·Jean-Christophe Rochet
Apr 28, 2010·Molecular BioSystems·James Shorter
Nov 10, 2006·The New England Journal of Medicine·Steven R Gullans
May 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Huan WangJames Shorter
Jun 1, 2010·The Journal of Biological Chemistry·Ali Reza A LadiwalaPeter M Tessier
Jul 29, 2011·The Journal of Biological Chemistry·Gonzalo R LambertoClaudio O Fernández
Apr 17, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dayong WangYang K Xiang
Mar 23, 2005·Brain Pathology·Berislav V ZlokovicJoseph M Miano
Oct 31, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adam R FergusonMichael S Beattie
Jan 29, 2014·Chemical Communications : Chem Comm·Atanu BiswasSurajit Ghosh
Sep 30, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tinsley H Davis
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ryan Simkovsky, Jonathan King
May 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Angela D WilliamsRonald Wetzel
Jan 29, 2008·Nature Chemical Biology·Brian Y FengBrian K Shoichet
Mar 11, 2005·Expert Opinion on Investigational Drugs·Sheila A Doggrell
Jun 30, 2006·Journal of Neurochemistry·Colin L MastersVictor L Villemagne
Dec 10, 2015·Journal of Diabetes Research·Amit PithadiaAyyalusamy Ramamoorthy
Aug 22, 2014·The Biochemical Journal·Katelyn M SeitherJames Shorter
Jul 15, 2015·Expert Opinion on Pharmacotherapy·Inga M AntonsdottirAnton P Porsteinsson
Oct 12, 2010·Prion·Martin L Duennwald, James Shorter
Apr 22, 2015·Biomolecules·Afsaneh PorzoorIan Macreadie
Jan 1, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tae-Wan Kim
May 4, 2016·International Journal of Biological Macromolecules·Atta AhmadMahvish Muzaffar
Nov 20, 2015·Journal of Diabetes Research·Marianna Flora TomaselloGiuseppe Pappalardo
Sep 12, 2009·Experimental Neurology·Kevin A DasilvaJoanne McLaurin
Apr 6, 2005·Drug Discovery Today·Hugo Geerts
Mar 2, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Syed Haris Omar
Nov 21, 2015·Chemical Communications : Chem Comm·Amit S PithadiaAyyalusamy Ramamoorthy
Jun 15, 2013·International Journal of Molecular Sciences·Massimo Stefani, Stefania Rigacci
Nov 5, 2011·Journal of Peptide Science : an Official Publication of the European Peptide Society·Chandrasekaran SivakamaSundariRamakrishnan Nagaraj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.